← FDA DRUG APPROVALS

FDA ANDA · ANDA090762

MYCOPHENOLATE MOFETIL

Sponsor: JUBILANT CADISTA

APPLICATION
ANDA090762
TYPE
ANDA
ORIGINAL APPROVAL
2014-12-15
LATEST ACTION
2026-07-29
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued

Products

MYCOPHENOLATE MOFETILDiscontinued
MYCOPHENOLATE MOFETIL 250MG · CAPSULE · ORAL

Approval history

2026-07-29REMS · Supplement 12AP
2024-08-13REMS · Supplement 11AP
2021-08-11REMS · Supplement 10AP
2021-04-21REMS · Supplement 9AP
2021-01-15REMS · Supplement 6AP
2016-07-27Labeling · Supplement 3 · standardAP
2015-11-13REMS · Supplement 2AP
2014-12-15OriginalOtherAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →